CECILIA JORGE: Open Payments
NPI 1043494537 · HOMESTEAD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$576 in 28 payments from 10 companies in 2025. Trend: 2023 $827 · 2024 $623 · 2025 $576
Food & beverage: $576
| Company | Payments | Amount |
|---|---|---|
| Almatica Pharma LLC | 7 | $157 |
| Otsuka America Pharmaceutical, Inc. | 5 | $96 |
| Tris Pharma Inc | 4 | $78 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $70 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| Neuronetics, Inc. | 2 | $37 |
| Supernus Pharmaceuticals, Inc. | 2 | $37 |
| ABBVIE INC. | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
Products named: LOREEV XR, REXULTI, Dyanavel XR, CAPLYTA, Auvelity, NEUROSTAR TMS THERAPY SYSTEM, Qelbree, VRAYLAR.
Industry payments across FL — which companies pay providers there.
